# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Joseph Pantginis reiterates Mustang Bio (NASDAQ:MBIO) with a Buy and maintains $2 price target.
HC Wainwright & Co. analyst Joseph Pantginis maintains Mustang Bio (NASDAQ:MBIO) with a Buy, adjusts target to $2 from $25.
Mustang Bio announced the pricing of a public offering of an aggregate of 16,877,638 shares of its common stock (or common stoc...
-SEC Filing